<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="cytoa24481" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cytometry A</journal-id><journal-id journal-id-type="iso-abbrev">Cytometry A</journal-id><journal-id journal-id-type="pmc-domain-id">379</journal-id><journal-id journal-id-type="pmc-domain">blackwellopen</journal-id><journal-id journal-id-type="publisher-id">CYTO</journal-id><journal-title-group><journal-title>Cytometry</journal-title></journal-title-group><issn pub-type="ppub">1552-4922</issn><issn pub-type="epub">1552-4930</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Wiley Open Access Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC9292053</article-id><article-id pub-id-type="pmcid-ver">PMC9292053.1</article-id><article-id pub-id-type="pmcaid">9292053</article-id><article-id pub-id-type="pmcaiid">9292053</article-id><article-id pub-id-type="pmid">34260151</article-id><article-id pub-id-type="doi">10.1002/cyto.a.24481</article-id><article-id pub-id-type="publisher-id">CYTOA24481</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Omip</subject></subj-group><subj-group subj-group-type="heading"><subject>Omip</subject></subj-group></article-categories><title-group><article-title>OMIP 077: Definition of all principal human leukocyte populations using a broadly applicable 14&#8208;color panel</article-title><alt-title alt-title-type="left-running-head">Boesch et al.</alt-title></title-group><contrib-group><contrib id="cytoa24481-cr-0001" contrib-type="author"><name name-style="western"><surname>Boesch</surname><given-names initials="M">Maximilian</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0994-9883</contrib-id><xref rid="cytoa24481-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="cytoa24481-cr-0002" contrib-type="author"><name name-style="western"><surname>Sykora</surname><given-names initials="M">Martina</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1612-3609</contrib-id><xref rid="cytoa24481-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cytoa24481-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="cytoa24481-cr-0003" contrib-type="author"><name name-style="western"><surname>Gasteiger</surname><given-names initials="S">Silvia</given-names></name><xref rid="cytoa24481-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="cytoa24481-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="cytoa24481-cr-0004" contrib-type="author"><name name-style="western"><surname>Baty</surname><given-names initials="F">Florent</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1425-0428</contrib-id><xref rid="cytoa24481-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="cytoa24481-cr-0005" contrib-type="author"><name name-style="western"><surname>Brutsche</surname><given-names initials="MH">Martin H.</given-names></name><xref rid="cytoa24481-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="cytoa24481-cr-0006" contrib-type="author" corresp="yes"><name name-style="western"><surname>Sopper</surname><given-names initials="S">Sieghart</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2265-1974</contrib-id><xref rid="cytoa24481-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cytoa24481-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><address><email>sieghart.sopper@i-med.ac.at</email></address></contrib></contrib-group><aff id="cytoa24481-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Lung Center</named-content>
<institution>Cantonal Hospital St.Gallen</institution>
<city>St.Gallen</city>
<named-content content-type="country-part">St.Gallen</named-content>
<country country="CH">Switzerland</country>
</aff><aff id="cytoa24481-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Internal Medicine V</named-content>
<institution>Medical University of Innsbruck</institution>
<city>Innsbruck</city>
<named-content content-type="country-part">Tyrol</named-content>
<country country="AT">Austria</country>
</aff><aff id="cytoa24481-aff-0003">
<label>
<sup>3</sup>
</label>
<institution>Tyrolean Cancer Research Institute</institution>
<city>Innsbruck</city>
<named-content content-type="country-part">Tyrol</named-content>
<country country="AT">Austria</country>
</aff><aff id="cytoa24481-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Visceral, Transplant and Thoracic Surgery</named-content>
<institution>Medical University of Innsbruck</institution>
<city>Innsbruck</city>
<named-content content-type="country-part">Tyrol</named-content>
<country country="AT">Austria</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/> Sieghart Sopper, Internal Medicine V, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.<break/>
Email: <email>sieghart.sopper@i-med.ac.at</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>14</day><month>7</month><year>2021</year></pub-date><pub-date pub-type="ppub"><month>1</month><year>2022</year></pub-date><volume>101</volume><issue seq="90">1</issue><issue-id pub-id-type="pmc-issue-id">412625</issue-id><issue-id pub-id-type="doi">10.1002/cyto.a.v101.1</issue-id><fpage>15</fpage><lpage>20</lpage><history><date date-type="rev-recd"><day>09</day><month>6</month><year>2021</year></date><date date-type="received"><day>13</day><month>10</month><year>2020</year></date><date date-type="accepted"><day>29</day><month>6</month><year>2021</year></date></history><pub-history><event event-type="pmc-release"><date><day>18</day><month>07</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>20</day><month>07</month><year>2022</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2022-07-27 07:16:54.307"><day>27</day><month>07</month><year>2022</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2021 The Authors. <italic toggle="yes">Cytometry Part A</italic> published by Wiley Periodicals LLC on behalf of International Society for Advancement of Cytometry.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#8208;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="CYTO-101-15.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:CYTO-101-15.pdf"/><abstract><title>Abstract</title><p>This Optimized Multicolor Immunofluorescence Panel was designed to identify and quantify all principal leukocyte populations in human blood using a minimum number of markers. We achieved this goal using a carefully selected combination of 14 surface markers compatible with standard flow cytometric instruments and accessible to a particularly large research community. Optimized for use in whole blood, this panel allows polymorphonuclear cell identification, supports live cell recovery, and is well&#8208;suited for absolute cell counting applications in the original in vivo volume. Panel performance and the separation of populations are high, and virtually no cells remain undefined after gating. Besides the identification of neutrophils, eosinophils, basophils, T cells, natural killer cells, B cells, plasma cells, monocytes, myeloid dendritic cells and plasmacytoid dendritic cells, this panel also covers progenitor cells and may therefore be attractive for stem cell researchers. Envisioned applications of this panel include immune monitoring within clinical trials, initial discovery to inform subset&#8208;targeted panels, and clinical diagnostics. In summary, this panel offers a broadly applicable platform for immune cell identification, quantification and characterization in human samples, particularly whole blood.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="cytoa24481-kwd-0001">absolute cell counting</kwd><kwd id="cytoa24481-kwd-0002">flow cytometry</kwd><kwd id="cytoa24481-kwd-0003">immune monitoring</kwd><kwd id="cytoa24481-kwd-0004">immune phenotyping</kwd><kwd id="cytoa24481-kwd-0005">leukocyte</kwd><kwd id="cytoa24481-kwd-0006">PBMC</kwd><kwd id="cytoa24481-kwd-0007">whole blood</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Austrian Research Promotion Agency
</institution><institution-id institution-id-type="doi">10.13039/501100004955</institution-id></institution-wrap></funding-source><award-id>858057 (HD FACS)</award-id></award-group></funding-group><counts><fig-count count="1"/><table-count count="2"/><page-count count="6"/><word-count count="3231"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY-NC-ND</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>January 2022</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.1.7 mode:remove_FC converted:18.07.2022</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="cytoa24481-cit-9001"><string-name name-style="western"><surname>Boesch</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Sykora</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Gasteiger</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Baty</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Brutsche</surname><given-names>MH</given-names></string-name>, <string-name name-style="western"><surname>Sopper</surname><given-names>S</given-names></string-name>. <article-title>OMIP 077: Definition of all principal human leukocyte populations using a broadly applicable 14&#8208;color panel</article-title>. <source>Cytometry</source>. <year>2022</year>;<volume>101</volume>:<fpage>15</fpage>&#8211;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1002/cyto.a.24481</pub-id><pub-id pub-id-type="pmid">34260151</pub-id><pub-id pub-id-type="pmcid">PMC9292053</pub-id></mixed-citation>
</p><fn-group id="cytoa24481-ntgp-0001"><fn id="cytoa24481-note-0001" fn-type="equal"><p>Maximilian Boesch and Martina Sykora contributed equally to this work.</p></fn><fn id="cytoa24481-note-1002"><p>
<bold>Funding information</bold> Austrian Research Promotion Agency, Grant/Award Number: 858057 (HD FACS)</p></fn></fn-group></notes></front><body id="cytoa24481-body-0001"><def-list list-content="abbreviations" id="cytoa24481-lp-0001"><title>Abbreviations</title><def-item><term id="cytoa24481-li-0001">APC</term><def id="cytoa24481-li-0002"><p>Allophycocyanin</p></def></def-item><def-item><term id="cytoa24481-li-0003">BV</term><def id="cytoa24481-li-0004"><p>Brilliant Violet</p></def></def-item><def-item><term id="cytoa24481-li-0005">FCM</term><def id="cytoa24481-li-0006"><p>flow cytometry</p></def></def-item><def-item><term id="cytoa24481-li-0007">FITC</term><def id="cytoa24481-li-0008"><p>fluorescein isothiocyanate</p></def></def-item><def-item><term id="cytoa24481-li-0009">FSC</term><def id="cytoa24481-li-0010"><p>forward scatter</p></def></def-item><def-item><term id="cytoa24481-li-0011">MCM</term><def id="cytoa24481-li-0012"><p>mass cytometry</p></def></def-item><def-item><term id="cytoa24481-li-0013">mDC</term><def id="cytoa24481-li-0014"><p>myeloid dendritic cell</p></def></def-item><def-item><term id="cytoa24481-li-0015">Monocyte (c/nc)</term><def id="cytoa24481-li-0016"><p>classical/nonclassical monocyte</p></def></def-item><def-item><term id="cytoa24481-li-0017">MZB</term><def id="cytoa24481-li-0018"><p>marginal zone B</p></def></def-item><def-item><term id="cytoa24481-li-0019">NK</term><def id="cytoa24481-li-0020"><p>natural killer</p></def></def-item><def-item><term id="cytoa24481-li-0021">NKT</term><def id="cytoa24481-li-0022"><p>natural killer T</p></def></def-item><def-item><term id="cytoa24481-li-0023">OMIP</term><def id="cytoa24481-li-0024"><p>optimized multicolor immunofluorescence panel</p></def></def-item><def-item><term id="cytoa24481-li-0025">opt&#8208;SNE</term><def id="cytoa24481-li-0026"><p>optimized t&#8208;distributed stochastic neighbor embedding</p></def></def-item><def-item><term id="cytoa24481-li-0027">PBMC</term><def id="cytoa24481-li-0028"><p>peripheral blood mononuclear cell</p></def></def-item><def-item><term id="cytoa24481-li-0029">pDC</term><def id="cytoa24481-li-0030"><p>plasmacytoid dendritic cell</p></def></def-item><def-item><term id="cytoa24481-li-0031">PE</term><def id="cytoa24481-li-0032"><p>phycoerythrin</p></def></def-item><def-item><term id="cytoa24481-li-0033">PerCP</term><def id="cytoa24481-li-0034"><p>peridinin&#8208;chlorophyll&#8208;protein complex</p></def></def-item><def-item><term id="cytoa24481-li-0035">SSC</term><def id="cytoa24481-li-0036"><p>side scatter</p></def></def-item><def-item><term id="cytoa24481-li-0037">WB</term><def id="cytoa24481-li-0038"><p>whole blood</p></def></def-item></def-list><sec id="cytoa24481-sec-0001"><label>1</label><title>PURPOSE AND APPROPRIATE SAMPLE TYPES</title><p>The present optimized multicolor immunofluorescence panel (OMIP) provides for the detection and in&#8208;depth analysis of all major leukocyte subsets in human whole blood (WB) using a single flow cytometry (FCM) panel with just 14 colors (Table&#160;<xref rid="cytoa24481-tbl-0001" ref-type="table">1</xref>). The panel offers an easy, fast and reproducible way of comprehensive immune cell profiling for various purposes including translational research and companion immune monitoring of clinical trials. Of note, the panel has been specifically designed to analyze erythrocyte&#8208;depleted WB, hence allowing the characterization of polymorphonuclear cells in addition to the widely used peripheral blood mononuclear cells (PBMCs). The use of WB instead of density gradient&#8208;enriched material further permits absolute cell counting in the original sample volume. Other notable assets are the detection of hematopoietic progenitors as well as the possibility for myeloid dendritic cell subset discrimination. In contrast to high&#8208;dimensional FCM or mass cytometry (MCM) panels, this 14&#8208;color panel does not require high&#8208;end instrumentation and is therefore accessible to a particularly broad research community.</p><table-wrap position="float" id="cytoa24481-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Summary table for application of this OMIP</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Purpose</th><th align="left" valign="bottom" rowspan="1" colspan="1">Comprehensive phenotyping of leukocyte subsets in WB using flow cytometry with just 14 colors</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Species</td><td align="left" valign="top" rowspan="1" colspan="1">Human (<italic toggle="yes">Homo sapiens</italic>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cell types</td><td align="left" valign="top" rowspan="1" colspan="1">Leukocytes from human WB (anticoagulated, erythrocyte&#8208;depleted)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cross references</td><td align="left" valign="top" rowspan="1" colspan="1">OMIP&#8208;023, OMIP&#8208;024, OMIP&#8208;042, OMIP&#8208;051, OMIP&#8208;063</td></tr></tbody></table><table-wrap-foot id="cytoa24481-ntgp-0002"><fn id="cytoa24481-note-0002"><p>Abbreviations: OMIP, optimized multicolor immunofluorescence panel; WB, whole blood.</p></fn></table-wrap-foot></table-wrap><p>This OMIP has been optimized in terms of (i) phenotyping depth (goal: to cover all major leukocyte subsets in WB with a minimum number of markers), (ii) the antibodies used (goal: to reduce unspecific binding), (iii) the fluorochromes used (goal: to maximize the staining index while limiting channel spillover), (iv) the expression levels of the individual antigens (goal: to use bright fluorochromes for lowly expressed antigens and vice versa), and (v) user&#8208;friendliness and applicability (goal: to provide an easy and fast method compatible with standard FCM instruments).</p></sec><sec id="cytoa24481-sec-0002"><label>2</label><title>BACKGROUND</title><p>High&#8208;dimensional single cell analysis using FCM [<xref rid="cytoa24481-bib-0001" ref-type="bibr">1</xref>, <xref rid="cytoa24481-bib-0002" ref-type="bibr">2</xref>] or MCM [<xref rid="cytoa24481-bib-0003" ref-type="bibr">3</xref>] has provided unprecedented insights into the cellular makeup of heterogeneous samples. However, considering that the number of theoretical populations increases exponentially with every marker dimension added [<xref rid="cytoa24481-bib-0004" ref-type="bibr">4</xref>, <xref rid="cytoa24481-bib-0005" ref-type="bibr">5</xref>] and that the complexity of data analysis and interpretation rises alongside, the benefit of high&#8208;dimensional cytometry for a given study has to be carefully weighted. This is especially true for clinical applications where immune profiling of a high number of samples shall robustly assess the influence of a tested medicine on the abundance and phenotype of the major immune cell lineages even in a multicenter setting [<xref rid="cytoa24481-bib-0006" ref-type="bibr">6</xref>] rather than analyzing a maximum number of populations or deciphering developmental trajectories [<xref rid="cytoa24481-bib-0007" ref-type="bibr">7</xref>]. Hence, there is room for limited&#8208;color FCM panels nevertheless capable of resolving all major leukocyte subsets in humans. The present OMIP shall occupy this niche and leverage the low&#8208;threshold access to comprehensive FCM&#8208;based immune phenotyping in laboratories around the globe. Notably, the present OMIP was specifically designed to produce clear populations and be applicable to multiple instruments from various manufacturers even without normalization.</p><p>After several months of development and optimization (see Online <xref rid="cytoa24481-supitem-0001" ref-type="supplementary-material">supplement</xref>), we arrived at the 14&#8208;color panel shown in Table&#160;<xref rid="cytoa24481-tbl-0002" ref-type="table">2</xref>, exclusively targeting surface markers. After general gating steps involving (i) the prospective identification of pan&#8208;leukocytes using CD45 expression, (ii) the exclusion of dead cells and debris based on FSC/SSC characteristics, (iii) the exclusion of doublets and aggregates using the different signals of FSC and, if applicable, (iv) the exclusion of counting bead contamination (Figure&#160;<xref rid="cytoa24481-fig-0001" ref-type="fig">1(A)</xref>), PBMCs are separated from granulocytes using a bivariate SSC/CD14 plot (Figure&#160;<xref rid="cytoa24481-fig-0001" ref-type="fig">1(B)</xref>). CD15<sup>+</sup> granulocytes are subsequently divided into CD193<sup>&#8722;</sup>/CD16<sup>+/&#8722;</sup> neutrophils and CD193<sup>+</sup> eosinophils. Within the CD3<sup>+</sup> T cell&#8208;excluded PBMC compartment, CD34<sup>+</sup> progenitor cells as well as CD193<sup>+</sup> basophils are defined. The bulk of CD34/CD193 double&#8208;negative cells contain HLA&#8208;DR<sup>&#8722;</sup>/CD14<sup>&#8722;</sup> natural killer (NK) cells expressing CD56 (and for the most part CD16) as well as populations of HLA&#8208;DR/CD14 single&#8208; or double&#8208;positive cells. This latter fraction comprises monocyte populations that express CD14 and/or CD16 as well as a population of CD14/CD16 double&#8208;negative cells. CD14<sup>&#8722;</sup>/CD16<sup>&#8722;</sup> cells mostly consist of CD19/CD38 single&#8208; or double&#8208;positive cells in turn representing CD19<sup>+</sup> B cells, CD38<sup>+</sup> plasma cells and CD1c<sup>+</sup> marginal zone B (MZB) cells. The CD19<sup>&#8722;</sup>/CD38<sup>dim</sup> fraction contains both CD1c<sup>+</sup> myeloid dendritic cells (mDCs) and CD123<sup>+</sup> plasmacytoid dendritic cells (pDCs). Finally, the CD1c/CD123 double&#8208;negative cell fraction contains CD141<sup>+</sup> mDCs. The discriminatory power of the panel is excellent as evidenced by optimized t&#8208;distributed stochastic neighbor embedding (opt&#8208;SNE) analysis which shows unambiguous separation of the various cell populations downstream of the leukocyte (Figure&#160;<xref rid="cytoa24481-fig-0001" ref-type="fig">1(C)</xref>) or PBMC (Figure&#160;<xref rid="cytoa24481-fig-0001" ref-type="fig">1(D)</xref>) denominators. Moreover, the panel has a very high coverage such that virtually no cells remain undefined after gating. For the clear demarcation of individual populations, it is therefore essential that all populations be gated so as to exploit the panel's full potential and definitely avoid the false allocation of cells (particularly relevant for minor populations). Collectively, this carefully selected, limited&#8208;color flow panel allows for the unambiguous definition of all principal leukocyte subsets in human WB using a convenient and fast one&#8208;step/single&#8208;tube staining procedure. The single&#8208;tube nature of our assay not only is convenient and efficient, it also allows the analysis of very small amounts of blood (relevant for newborns) as well as the collection of as much information as possible. A comprehensive list of relative antigen expression for each marker for each cell type is provided in <xref rid="cytoa24481-supitem-0001" ref-type="supplementary-material">Online Table 4</xref>.</p><table-wrap position="float" id="cytoa24481-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>Summary table of antibodies used in this OMIP</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Specificity</th><th align="left" valign="bottom" rowspan="1" colspan="1">Fluorochrome</th><th align="left" valign="bottom" rowspan="1" colspan="1">Clone</th><th align="left" valign="bottom" rowspan="1" colspan="1">Purpose/definition of</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">CD1c</td><td align="left" valign="top" rowspan="1" colspan="1">PE</td><td align="left" valign="top" rowspan="1" colspan="1">AD5&#8208;8E7</td><td align="left" valign="top" rowspan="1" colspan="1">CD1c<sup>+</sup> mDCs, MZB cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD3</td><td align="left" valign="top" rowspan="1" colspan="1">BV605</td><td align="left" valign="top" rowspan="1" colspan="1">OKT3</td><td align="left" valign="top" rowspan="1" colspan="1">T cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD14</td><td align="left" valign="top" rowspan="1" colspan="1">BV711</td><td align="left" valign="top" rowspan="1" colspan="1">M&#934;P9</td><td align="left" valign="top" rowspan="1" colspan="1">Monocytes (c), intermediate monocytes, monocytes (nc)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD15</td><td align="left" valign="top" rowspan="1" colspan="1">PerCP&#8208;Cy5.5</td><td align="left" valign="top" rowspan="1" colspan="1">HI98</td><td align="left" valign="top" rowspan="1" colspan="1">Eosinophils</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD16</td><td align="left" valign="top" rowspan="1" colspan="1">APC&#8208;efluor780</td><td align="left" valign="top" rowspan="1" colspan="1">ebioCB16</td><td align="left" valign="top" rowspan="1" colspan="1">Neutrophils, intermediate monocytes, monocytes (nc)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD19</td><td align="left" valign="top" rowspan="1" colspan="1">APC&#8208;R700</td><td align="left" valign="top" rowspan="1" colspan="1">HIB19</td><td align="left" valign="top" rowspan="1" colspan="1">B cells, plasma cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD34</td><td align="left" valign="top" rowspan="1" colspan="1">FITC</td><td align="left" valign="top" rowspan="1" colspan="1">HPCA&#8208;2</td><td align="left" valign="top" rowspan="1" colspan="1">Progenitor cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD38</td><td align="left" valign="top" rowspan="1" colspan="1">BV421</td><td align="left" valign="top" rowspan="1" colspan="1">HIT2</td><td align="left" valign="top" rowspan="1" colspan="1">Plasma cells, basophils</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD45</td><td align="left" valign="top" rowspan="1" colspan="1">BV480</td><td align="left" valign="top" rowspan="1" colspan="1">HI30</td><td align="left" valign="top" rowspan="1" colspan="1">Pan&#8208;leukocytes</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD56</td><td align="left" valign="top" rowspan="1" colspan="1">PE&#8208;Cy7</td><td align="left" valign="top" rowspan="1" colspan="1">NCAM16.2</td><td align="left" valign="top" rowspan="1" colspan="1">NK cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD123</td><td align="left" valign="top" rowspan="1" colspan="1">BV650</td><td align="left" valign="top" rowspan="1" colspan="1">7G3</td><td align="left" valign="top" rowspan="1" colspan="1">Basophils, pDCs</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD141</td><td align="left" valign="top" rowspan="1" colspan="1">APC</td><td align="left" valign="top" rowspan="1" colspan="1">AD5&#8208;14H12</td><td align="left" valign="top" rowspan="1" colspan="1">CD141<sup>+</sup> mDCs</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD193</td><td align="left" valign="top" rowspan="1" colspan="1">PE&#8208;CF594</td><td align="left" valign="top" rowspan="1" colspan="1">5E8</td><td align="left" valign="top" rowspan="1" colspan="1">Eosinophils, basophils</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HLA&#8208;DR</td><td align="left" valign="top" rowspan="1" colspan="1">BV786</td><td align="left" valign="top" rowspan="1" colspan="1">G46&#8208;6</td><td align="left" valign="top" rowspan="1" colspan="1">Neutrophils, monocytes (c), intermediate monocytes, monocytes (nc), B cells, plasma cells, CD1c<sup>+</sup> mDCs, CD141<sup>+</sup> mDCs</td></tr></tbody></table><table-wrap-foot id="cytoa24481-ntgp-0003"><fn id="cytoa24481-note-0003"><p>Abbreviations: mDC, myeloid dendritic cell; monocyte (c/nc), classical/non&#8208;classical monocyte; MZB, marginal zone B cell; NK, natural killer; OMIP, optimized multicolor immunofluorescence panel; pDC, plasmacytoid dendritic cell.</p></fn></table-wrap-foot></table-wrap><fig position="float" fig-type="FIGURE" id="cytoa24481-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Gating strategy and performance of this OMIP. (A) General gating strategy for identifying single viable leukocytes in human WB. Note that the last gating step is only applicable when counting beads were included in the staining. (B) Exemplary gating strategy for identifying the principal cell populations downstream of the leukocyte denominator. (C) Opt&#8208;SNE plot showing the separation of leukocyte populations in human WB. (D) Opt&#8208;SNE plot showing the separation of PBMC populations in human WB. mDC, myeloid dendritic cell; MZB, marginal zone B; monocyte (c/nc), classical/nonclassical monocyte; NK, natural killer; NKT, natural killer T; OMIP, optimized multicolor immunofluorescence panel; PBMC, peripheral blood mononuclear cell; pDC, plasmacytoid dendritic cell; opt&#8208;SNE, optimized t&#8208;distributed stochastic neighbor embedding; WB, whole blood. <named-content content-type="attribution">
<italic toggle="yes">Note</italic>: Data as shown here were acquired on a 3&#8208;laser BD LSRFortessa flow cytometric instrument (BD biosciences)</named-content> [Color figure can be viewed at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://wileyonlinelibrary.com" ext-link-type="uri">wileyonlinelibrary.com</ext-link>]</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="CYTO-101-15-g001.jpg"/></fig><p>As per intent, the here presented panel does not target minor cell subsets downstream of respective denominator populations, such as regulatory T cells (downstream of CD3 [<xref rid="cytoa24481-bib-0008" ref-type="bibr">8</xref>]) and certain subsets of NK cells and innate lymphoid cells (downstream of CD56 [<xref rid="cytoa24481-bib-0009" ref-type="bibr">9</xref>, <xref rid="cytoa24481-bib-0010" ref-type="bibr">10</xref>, <xref rid="cytoa24481-bib-0011" ref-type="bibr">11</xref>]). Instead, this panel is intended as a general and broadly applicable immune profiling platform that may also serve as a starting point for more specialized investigations based on subset&#8208;targeted panels, panels specific for cell activation/exhaustion, or panels discriminating effector from memory phenotypes. Nevertheless, this panel supports the collection of information beyond the main target populations it was designed for. As an example, the combination of CD3 and CD56 allows for the detection and quantification of NKT cells [<xref rid="cytoa24481-bib-0012" ref-type="bibr">12</xref>] and the combination of CD19 and CD1c enables MZB cell delineation [<xref rid="cytoa24481-bib-0013" ref-type="bibr">13</xref>] (Figure&#160;<xref rid="cytoa24481-fig-0001" ref-type="fig">1</xref>). In addition, the panel permits the analysis of HLA&#8208;DR expression on non&#8208;antigen&#8208;presenting cells such as T cells [<xref rid="cytoa24481-bib-0014" ref-type="bibr">14</xref>] and allows for the quantification of HLA&#8208;DR and CD38 double&#8208;positive cells, an activated T cell subpopulation, which has regained interest in the SARS&#8208;CoV&#8208;2 pandemic [<xref rid="cytoa24481-bib-0015" ref-type="bibr">15</xref>, <xref rid="cytoa24481-bib-0016" ref-type="bibr">16</xref>].</p><p>We waived the use of a dead cell discrimination marker since cell viability in blood is generally high such that exclusion of the remaining dead cells by means of FSC/SSC characteristics was deemed appropriate and sufficient. However, this panel can be adopted in whole or in part to analyze leukocytes from other tissue sources and a dead cell discrimination marker may then be considered (especially after tissue disaggregation). The use of WB instead of buffy coats re&#8208;prioritizes polymorphonuclear cells and permits absolute cell counting in the original in vivo volume (<xref rid="cytoa24481-supitem-0001" ref-type="supplementary-material">Online Figure 5</xref>), thus reducing experimental variation especially in the case of minor cell populations [<xref rid="cytoa24481-bib-0017" ref-type="bibr">17</xref>]. Further assets are the detection of CD34<sup>+</sup> hematopoietic progenitor cells (highly relevant for leukemia stem cell research [<xref rid="cytoa24481-bib-0018" ref-type="bibr">18</xref>]) as well as the possibility for live cell recovery for functional testing.</p><p>In summary, we present a versatile, surface marker&#8208;only, 14&#8208;color flow panel for the prospective identification of all major immune cell lineages in human WB. Standard flow cytometric instruments of various brands support this panel, which is hence accessible to a particularly large number of researchers. Although a plethora of research questions can be addressed with this OMIP, envisaged key applications are (i) companion immune profiling of clinical trials and (ii) initial discovery paving the way for more specialized panels. Moreover, our panel may be adopted for use in clinical diagnostics based on novel 3&#8208;laser instruments such as 12&#8208;color FACSLyric (BD Biosciences) and 13&#8208;color DxFLEX (Beckman Coulter). In this case, select markers would need to be omitted and prime candidates for this purpose would be CD15 and CD193 considering that neutrophils and eosinophils can usually be sufficiently discriminated using SSC/autofluorescence/CD16 characteristics or, alternatively, be enumerated by a differential blood count.</p></sec><sec id="cytoa24481-sec-0003"><label>3</label><title>SIMILARITY TO OTHER <styled-content style="fixed-case" toggle="no">OMIPs</styled-content>
</title><p>This OMIP has a partially overlapping scope with OMIP&#8208;023 [<xref rid="cytoa24481-bib-0019" ref-type="bibr">19</xref>], OMIP&#8208;024 [<xref rid="cytoa24481-bib-0020" ref-type="bibr">20</xref>], OMIP&#8208;042 [<xref rid="cytoa24481-bib-0021" ref-type="bibr">21</xref>], OMIP&#8208;051 [<xref rid="cytoa24481-bib-0001" ref-type="bibr">1</xref>], OMIP&#8208;063 [<xref rid="cytoa24481-bib-0022" ref-type="bibr">22</xref>]. However, many of these OMIPs incorporate significantly more markers (OMIP&#8208;042, OMIP&#8208;051, OMIP&#8208;063) and are hence not compatible with standard FCM instruments. Furthermore, many of these OMIPs are optimized for PBMC analysis (OMIP&#8208;024, OMIP&#8208;042, OMIP&#8208;051, and OMIP&#8208;063) and therefore do not consider or prioritize polymorphonuclear cells. While the here presented OMIP does not emphasize cell subsetting downstream of principal denominator populations, it is certainly unique in detecting both CD34<sup>+</sup> progenitor cells and mDC divergence (CD1c<sup>+</sup> vs. CD141<sup>+</sup>).</p></sec><sec sec-type="COI-statement" id="cytoa24481-sec-0005"><title>CONFLICT OF INTEREST</title><p>The authors have no potential conflicts of interest to declare. No medical writer or other non&#8208;author was involved in the preparation of the manuscript.</p></sec><sec id="cytoa24481-sec-0006"><title>AUTHOR CONTRIBUTIONS</title><p>
<bold>Maximilian Boesch:</bold> Conceptualization; data curation; formal analysis; validation; visualization; writing&#8208;original draft; writing&#8208;review &amp; editing. <bold>Martina Sykora:</bold> Conceptualization; data curation; formal analysis; investigation; methodology; validation; visualization; writing&#8208;review &amp; editing. <bold>Silvia Gasteiger:</bold> Investigation; writing&#8208;review &amp; editing. <bold>Florent Baty:</bold> Formal analysis; resources; validation; writing&#8208;review &amp; editing. <bold>Martin H. Brutsche:</bold> Formal analysis; resources; validation; writing&#8208;review &amp; editing. <bold>Sieghart Sopper:</bold> Conceptualization; data curation; formal analysis; funding acquisition; investigation; methodology; project administration; resources; supervision; visualization; writing&#8208;original draft; writing&#8208;review &amp; editing.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="cytoa24481-supitem-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Appendix</bold> S1: Supporting Information.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-101-15-s001.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="cytoa24481-supitem-0002" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>MIFlowCyt</bold> MIFlowCyt Item Checklist.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-101-15-s002.doc" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack id="cytoa24481-sec-0004"><title>ACKNOWLEDGMENTS</title><p>The authors would like to thank Elisabeth Hoflehner, Petra Schumacher, Miriam Zentgraf, and Iris Krainer for providing excellent technical assistance. This work was supported by the Austrian Research Promotion Agency under grant number 858057 (HD FACS).</p></ack><ref-list id="cytoa24481-bibl-0001" content-type="cited-references"><title>REFERENCES</title><ref id="cytoa24481-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="cytoa24481-cit-0001"><string-name name-style="western"><surname>Liechti</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Roederer</surname><given-names>M</given-names></string-name>. <article-title>OMIP&#8208;051 &#8208; 28&#8208;color flow cytometry panel to characterize B cells and myeloid cells</article-title>. <source>Cytometry A</source>. <year>2019</year>;<volume>95</volume>:<fpage>150</fpage>&#8211;<lpage>5</lpage>.<pub-id pub-id-type="pmid">30549419</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.23689</pub-id><pub-id pub-id-type="pmcid">PMC6546165</pub-id></mixed-citation></ref><ref id="cytoa24481-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="cytoa24481-cit-0002"><string-name name-style="western"><surname>Park</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Lannigan</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Jaimes</surname><given-names>MC</given-names></string-name>. <article-title>OMIP&#8208;069: forty&#8208;color full spectrum flow cytometry panel for deep Immunophenotyping of major cell subsets in human peripheral blood</article-title>. <source>Cytometry A</source>. <year>2020</year>;<volume>97</volume>:<fpage>1044</fpage>&#8211;<lpage>51</lpage>.<pub-id pub-id-type="pmid">32830910</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.24213</pub-id><pub-id pub-id-type="pmcid">PMC8132182</pub-id></mixed-citation></ref><ref id="cytoa24481-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="cytoa24481-cit-0003"><string-name name-style="western"><surname>Bendall</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Simonds</surname><given-names>EF</given-names></string-name>, <string-name name-style="western"><surname>Qiu</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>el Amir</surname><given-names>AD</given-names></string-name>, <string-name name-style="western"><surname>Krutzik</surname><given-names>PO</given-names></string-name>, <string-name name-style="western"><surname>Finck</surname><given-names>R</given-names></string-name>, et al. <article-title>Single&#8208;cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum</article-title>. <source>Science</source>. <year>2011</year>;<volume>332</volume>:<fpage>687</fpage>&#8211;<lpage>96</lpage>.<pub-id pub-id-type="pmid">21551058</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1198704</pub-id><pub-id pub-id-type="pmcid">PMC3273988</pub-id></mixed-citation></ref><ref id="cytoa24481-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="cytoa24481-cit-0004"><string-name name-style="western"><surname>Boesch</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Zeimet</surname><given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Reimer</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Schmidt</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Gastl</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Parson</surname><given-names>W</given-names></string-name>, et al. <article-title>The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics</article-title>. <source>Oncotarget</source>. <year>2014</year>;<volume>5</volume>:<fpage>7027</fpage>&#8211;<lpage>39</lpage>.<pub-id pub-id-type="pmid">25216521</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18632/oncotarget.2053</pub-id><pub-id pub-id-type="pmcid">PMC4196181</pub-id></mixed-citation></ref><ref id="cytoa24481-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="cytoa24481-cit-0005"><string-name name-style="western"><surname>Boesch</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Cosma</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Sopper</surname><given-names>S</given-names></string-name>. <article-title>Flow cytometry: to dump or not to dump</article-title>. <source>J Immunol</source>. <year>2018</year>;<volume>201</volume>:<fpage>1813</fpage>&#8211;<lpage>5</lpage>.<pub-id pub-id-type="pmid">30224359</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.1801037</pub-id></mixed-citation></ref><ref id="cytoa24481-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="cytoa24481-cit-0006"><string-name name-style="western"><surname>Sopper</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Mustjoki</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>White</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Hughes</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Valent</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Burchert</surname><given-names>A</given-names></string-name>, et al. <article-title>Reduced CD62L expression on T cells and increased soluble CD62L levels predict molecular response to tyrosine kinase inhibitor therapy in early chronic&#8208;phase chronic myelogenous leukemia</article-title>. <source>J Clin Oncol</source>. <year>2017</year>;<volume>35</volume>:<fpage>175</fpage>&#8211;<lpage>84</lpage>.<pub-id pub-id-type="pmid">28056193</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JCO.2016.67.0893</pub-id></mixed-citation></ref><ref id="cytoa24481-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="cytoa24481-cit-0007"><string-name name-style="western"><surname>Qiu</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Simonds</surname><given-names>EF</given-names></string-name>, <string-name name-style="western"><surname>Bendall</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Gibbs</surname><given-names>KD</given-names><suffix>Jr</suffix></string-name>, <string-name name-style="western"><surname>Bruggner</surname><given-names>RV</given-names></string-name>, <string-name name-style="western"><surname>Linderman</surname><given-names>MD</given-names></string-name>, et al. <article-title>Extracting a cellular hierarchy from high&#8208;dimensional cytometry data with SPADE</article-title>. <source>Nat Biotechnol</source>. <year>2011</year>;<volume>29</volume>:<fpage>886</fpage>&#8211;<lpage>91</lpage>.<pub-id pub-id-type="pmid">21964415</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nbt.1991</pub-id><pub-id pub-id-type="pmcid">PMC3196363</pub-id></mixed-citation></ref><ref id="cytoa24481-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="cytoa24481-cit-0008"><string-name name-style="western"><surname>Shevyrev</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Tereshchenko</surname><given-names>V</given-names></string-name>. <article-title>Treg heterogeneity, function, and homeostasis</article-title>. <source>Front Immunol</source>. <year>2019</year>;<volume>10</volume>:<fpage>3100</fpage>.<pub-id pub-id-type="pmid">31993063</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2019.03100</pub-id><pub-id pub-id-type="pmcid">PMC6971100</pub-id></mixed-citation></ref><ref id="cytoa24481-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="cytoa24481-cit-0009"><string-name name-style="western"><surname>Spits</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Artis</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Colonna</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Diefenbach</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Di Santo</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Eberl</surname><given-names>G</given-names></string-name>, et al. <article-title>Innate lymphoid cells&#8208;a proposal for uniform nomenclature</article-title>. <source>Nat Rev Immunol</source>. <year>2013</year>;<volume>13</volume>:<fpage>145</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="pmid">23348417</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nri3365</pub-id></mixed-citation></ref><ref id="cytoa24481-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="cytoa24481-cit-0010"><string-name name-style="western"><surname>Chen</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Youssef</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Robinson</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Ernst</surname><given-names>GF</given-names></string-name>, <string-name name-style="western"><surname>Carson</surname><given-names>MY</given-names></string-name>, <string-name name-style="western"><surname>Young</surname><given-names>KA</given-names></string-name>, et al. <article-title>CD56 expression marks human group 2 innate lymphoid cell divergence from a shared NK cell and group 3 innate lymphoid cell developmental pathway</article-title>. <source>Immunity</source>. <year>2018</year>;<volume>49</volume>:<fpage>464</fpage>&#8211;<lpage>76</lpage>. e4.<pub-id pub-id-type="pmid">30193847</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2018.08.010</pub-id><pub-id pub-id-type="pmcid">PMC6148384</pub-id></mixed-citation></ref><ref id="cytoa24481-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="cytoa24481-cit-0011"><string-name name-style="western"><surname>Eller</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Currier</surname><given-names>JR</given-names></string-name>. <article-title>OMIP&#8208;007: phenotypic analysis of human natural killer cells</article-title>. <source>Cytometry A</source>. <year>2012</year>;<volume>81</volume>:<fpage>447</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="pmid">22411905</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.22033</pub-id></mixed-citation></ref><ref id="cytoa24481-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="cytoa24481-cit-0012"><string-name name-style="western"><surname>Krijgsman</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>de Vries</surname><given-names>NL</given-names></string-name>, <string-name name-style="western"><surname>Skovbo</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Andersen</surname><given-names>MN</given-names></string-name>, <string-name name-style="western"><surname>Swets</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Bastiaannet</surname><given-names>E</given-names></string-name>, et al. <article-title>Characterization of circulating T&#8208;, NK&#8208;, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile</article-title>. <source>Cancer Immunol Immunother</source>. <year>2019</year>;<volume>68</volume>:<fpage>1011</fpage>&#8211;<lpage>24</lpage>.<pub-id pub-id-type="pmid">31053876</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00262-019-02343-7</pub-id><pub-id pub-id-type="pmcid">PMC6529387</pub-id></mixed-citation></ref><ref id="cytoa24481-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="cytoa24481-cit-0013"><string-name name-style="western"><surname>Cerutti</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Cols</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Puga</surname><given-names>I</given-names></string-name>. <article-title>Marginal zone B cells: virtues of innate&#8208;like antibody&#8208;producing lymphocytes</article-title>. <source>Nat Rev Immunol</source>. <year>2013</year>;<volume>13</volume>:<fpage>118</fpage>&#8211;<lpage>32</lpage>.<pub-id pub-id-type="pmid">23348416</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nri3383</pub-id><pub-id pub-id-type="pmcid">PMC3652659</pub-id></mixed-citation></ref><ref id="cytoa24481-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="cytoa24481-cit-0014"><string-name name-style="western"><surname>Arruvito</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Payaslian</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Baz</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Podhorzer</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Billordo</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Pandolfi</surname><given-names>J</given-names></string-name>, et al. <article-title>Identification and clinical relevance of naturally occurring human CD8+HLA&#8208;DR+ regulatory T cells</article-title>. <source>J Immunol</source>. <year>2014</year>;<volume>193</volume>:<fpage>4469</fpage>&#8211;<lpage>76</lpage>.<pub-id pub-id-type="pmid">25261474</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.1401490</pub-id></mixed-citation></ref><ref id="cytoa24481-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="cytoa24481-cit-0015"><string-name name-style="western"><surname>Mathew</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Giles</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Baxter</surname><given-names>AE</given-names></string-name>, <string-name name-style="western"><surname>Oldridge</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Greenplate</surname><given-names>AR</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>JE</given-names></string-name>, et al. <article-title>Deep immune profiling of COVID&#8208;19 patients reveals distinct immunotypes with therapeutic implications</article-title>. <source>Science</source>. <year>2020</year>;<volume>369</volume>(<issue>6508</issue>):<fpage>eabc8511</fpage>. <pub-id pub-id-type="doi">10.1126/science.abc8511</pub-id>.<pub-id pub-id-type="pmid">32669297</pub-id><pub-id pub-id-type="pmcid">PMC7402624</pub-id></mixed-citation></ref><ref id="cytoa24481-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="cytoa24481-cit-0016"><string-name name-style="western"><surname>Braun</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Loyal</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Frentsch</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Wendisch</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Georg</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Kurth</surname><given-names>F</given-names></string-name>, et al. <article-title>SARS&#8208;CoV&#8208;2&#8208;reactive T cells in healthy donors and patients with COVID&#8208;19</article-title>. <source>Nature</source>. <year>2020</year>;<volume>587</volume>(<issue>7833</issue>):<fpage>270</fpage>&#8208;<lpage>274</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2598-9</pub-id>.<pub-id pub-id-type="pmid">32726801</pub-id></mixed-citation></ref><ref id="cytoa24481-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="cytoa24481-cit-0017"><string-name name-style="western"><surname>Barnett</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Janossy</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Lubenko</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Matutes</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Newland</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Reilly</surname><given-names>JT</given-names></string-name>. <article-title>Guideline for the flow cytometric enumeration of CD34+ haematopoietic stem cells. Prepared by the CD34+ haematopoietic stem cell working party. General Haematology task force of the British Committee for Standards in Haematology</article-title>. <source>Clin Lab Haematol</source>. <year>1999</year>;<volume>21</volume>:<fpage>301</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="pmid">10646072</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1365-2257.1999.00253.x</pub-id></mixed-citation></ref><ref id="cytoa24481-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="cytoa24481-cit-0018"><string-name name-style="western"><surname>Holyoake</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Jiang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Eaves</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Eaves</surname><given-names>A</given-names></string-name>. <article-title>Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia</article-title>. <source>Blood</source>. <year>1999</year>;<volume>94</volume>:<fpage>2056</fpage>&#8211;<lpage>64</lpage>.<pub-id pub-id-type="pmid">10477735</pub-id></mixed-citation></ref><ref id="cytoa24481-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="cytoa24481-cit-0019"><string-name name-style="western"><surname>Bocsi</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Melzer</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Dahnert</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Tarnok</surname><given-names>A</given-names></string-name>. <article-title>OMIP&#8208;023: 10&#8208;color, 13 antibody panel for in&#8208;depth phenotyping of human peripheral blood leukocytes</article-title>. <source>Cytometry A</source>. <year>2014</year>;<volume>85</volume>:<fpage>781</fpage>&#8211;<lpage>4</lpage>.<pub-id pub-id-type="pmid">25132115</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.22505</pub-id></mixed-citation></ref><ref id="cytoa24481-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="cytoa24481-cit-0020"><string-name name-style="western"><surname>Moncunill</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Han</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Dobano</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>McElrath</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>De Rosa</surname><given-names>SC</given-names></string-name>. <article-title>OMIP&#8208;024: pan&#8208;leukocyte immunophenotypic characterization of PBMC subsets in human samples</article-title>. <source>Cytometry A</source>. <year>2014</year>;<volume>85</volume>:<fpage>995</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="pmid">25352070</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.22580</pub-id><pub-id pub-id-type="pmcid">PMC4457440</pub-id></mixed-citation></ref><ref id="cytoa24481-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="cytoa24481-cit-0021"><string-name name-style="western"><surname>Staser</surname><given-names>KW</given-names></string-name>, <string-name name-style="western"><surname>Eades</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Choi</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Karpova</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>DiPersio</surname><given-names>JF</given-names></string-name>. <article-title>OMIP&#8208;042: 21&#8208;color flow cytometry to comprehensively immunophenotype major lymphocyte and myeloid subsets in human peripheral blood</article-title>. <source>Cytometry A</source>. <year>2018</year>;<volume>93</volume>:<fpage>186</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="pmid">29288606</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.23303</pub-id><pub-id pub-id-type="pmcid">PMC6077845</pub-id></mixed-citation></ref><ref id="cytoa24481-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="cytoa24481-cit-0022"><string-name name-style="western"><surname>Payne</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Salomon</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Ma</surname><given-names>CS</given-names></string-name>. <article-title>OMIP&#8208;063: 28&#8208;color flow cytometry panel for broad human Immunophenotyping</article-title>. <source>Cytometry A</source>. <year>2020</year>;<volume>97</volume>:<fpage>777</fpage>&#8211;<lpage>81</lpage>.<pub-id pub-id-type="pmid">32298042</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.24018</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>